A Prospective Cohort Study Showing No Association Between Serum Sclerostin Level and Mortality in Maintenance Hemodialysis Patients

Conclusion: Serum sclerostin level was not an independent predictor of mortality in MHD patients after adjustment for several confounders. However, whether clinical interventions to modulate serum sclerostin levels in MHD patients would improve their survival remains to be determined.Kidney Blood Press Res 2018;43:1023 –1033
Source: Kidney and Blood Pressure Research - Category: Urology & Nephrology Source Type: research